B. Jamard

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the Autoimmunity and Rituximab Registry

Xavier Puéchal, Jacques‐Eric Gottenberg, Jean‐Marie Berthelot et al. · Arthritis Care & Research · 2011 · 106 citations

Life Sciences, Internal Medicine, Pharmacotherapy +17

Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis

Arnaud Constantin, Philippe Dieudé, Valérie Lauwers‐Cancès et al. · Arthritis & Rheumatism · 2004 · 37 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: data from DESIR cohort

Adeline Ruyssen‐Witrand, B. Jamard, Alain Cantagrel et al. · RMD Open · 2017 · 33 citations · Full text

Medicine, Orthopaedic Surgery, Radiology +17

Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes

Adeline Ruyssen‐Witrand, Grégory Guernec, Delphine Nigon et al. · Annals of the Rheumatic Diseases · 2014 · 30 citations

Medicine, Clinical Sciences, Internal Medicine +17